Table: Brightpath Biotherapeutics - 6-MTH group results

BrightPath Biotherapeutics Co

09/11/2018 06:00

Nov 9 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2018        Sep 30, 2017      Mar 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            142 mln             182 mln           150 mln    
                 (-22.0 pct)                           (-57.7 pct)  
  Operating     loss 826 mln        loss 685 mln        loss 2.20   
  Recurring     loss 822 mln        loss 685 mln        loss 2.20   
  Net             loss 1.02         loss 687 mln        loss 2.20   
  EPS          loss 24.31 yen      loss 18.45 yen    loss 52.59 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T